Navigation Links
Studies assess genetics, modified treatment to improve outcomes, reduce toxicity
Date:12/8/2012

a treatment associated with both short- and long-term toxicities.

ALL, the most common form of leukemia in children, is a fast-growing cancer of the white blood cells in which the bone marrow makes a large number of abnormal white blood cells that are unable to develop and fight infection. Important developments over the past 20 years have led to seminal insights about ALL in children, and today nearly 90 percent of children diagnosed with standard-risk ALL are cured. Some treatment regimens for standard-risk ALL include initial infusions of daunorubicin, a type of anthracycline. While effective, continual use of this therapy is associated with potential long-term heart damage, leading researchers to assess whether eliminating or reducing the dosage of daunorubicin during the initial one-month induction therapy period might provide the same level of efficacy as the standard treatment protocol with reduced long-term risk.

In order to assess the efficacy of ALL treatment without daunorubicin during induction therapy, a team of researchers from 20 centers across France and one center in Belgium initiated a multicenter Phase III clinical trial in which 1,128 pediatric patients with standard-risk B-cell ALL were randomized into two treatment arms. Arm A included 560 patients who received a standard dose of daunorubicin during induction therapy, while Arm B included 568 patients who did not receive initial therapy with daunorubicin. Both groups received doxorubicin during delayed intensification (last treatment phase before reaching maintenance) and a standard protocol of 24-month maintenance therapy from December 2000 to June 2010, during which five-year event-free survival (EFS) and overall survival (OS) were assessed.

For those patients treated with daunorubicin, the five-year EFS rate was 92.9 percent, compared to 93.3 percent in the non-daunorubicin arm. Overall survival rates were 97.2 percent and 98.2 percent in the daunorubicin and n
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. John Theurer Cancer Center to present 37 studies at the 2012 ASH Annual Meeting
2. Benefit6 Whole Body Protection, a New Product by I Do Strive LLC, Provides Increased Energy Production According to Recent Studies
3. Sharp spike in computer-related injuries predicted for medical workers, find studies
4. Analysis of conflicting fish oil studies finds that omega-3 fatty acids still matter
5. Studies from 2012 Quality Care Symposium highlight findings in improving quality of cancer care
6. New studies show effects of mammography guideline changes
7. 2 NIH studies show power of epidemiology research; Underscore need to address health disparities
8. Scripps studies show community-based diabetes programs are key to lowered costs and improved care
9. Cancer Drug Reduced Relapses in MS Patients: Studies
10. University of Houston India Studies Program presents Circuits of Empire: India as Metropole
11. Studies Show Limits, Promise of Laser Removal of Tattoos
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... CBT News.com recently announced the addition of Tom ... automotive industry news organization with 12 years experience in online ... a group that’s so forward-thinking in their approach,” says Gonter. ... content is on the rise.” , Atlanta born and raised, ... into advertising at Cycle News and Boating World. He made ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 DiscountHumidifiers.com, an ... launch of the new Broksonic line of ... array of color options with two styles to choose ... the appearance of a modern accent piece – yet ... operation and artful styling makes it an inconspicuous humidifying ...
(Date:5/24/2013)... German . ... accumulates within neurons. Specific areas of the brain become ... mechanism underlying this pathological progression is poorly understood but ... forms of it) along nerve projections connecting lower to ... for Neurodegenerative Diseases (DZNE) in Bonn have developed a ...
(Date:5/24/2013)... 2013 The creative flair and design ... University (PolyU)'s Institute of Textiles and Clothing (ITC) have ... Fashion Show held on 22 May at The Mira ... of ITC design students, various knitwear producers and yarn ... collections of four outfits from 20 graduating students majoring ...
(Date:5/24/2013)... Salt Lake City, UT (PRWEB) May 24, 2013 ... of MonaVie Latin America, as a new member of the ... , “I am proud to have been elected to this ... the ethical basis of the direct selling industry,” says Patrocinio. ... is a positive contributor to Brazil’s economy. The direct selling ...
Breaking Medicine News(10 mins):Health News:DiscountHumidifiers.com Announces the Launch of the New Broksonic Humidifiers to their Online Store 2Health News:Proteins in migration 2Health News:Proteins in migration 3Health News:Proteins in migration 4Health News:PolyU Stages Knitwear Fashion Show 2Health News:MonaVie Brazil Executive Elected to Ethics Board of ABEVD 2
... neural stem cells and their potential for someday treating diseases ... identified “cancer stem cells,” a small population of cells that ... brain tumor. Theoretically, if these mother cells can be destroyed, ... the other hand, if these cells are not removed or ...
... China's growing strengths in medical research, British Prime Minister ... medical excellence cluster' comprising// universities and drugs companies. ... England to protect Britain's science base and boost its ... of measures initiated by government functionaries while citing the ...
... of becoming infected with lymphocytic choriomeningitis virus (LCMV), an ... that can cause severe brain damage in a fetus. ... in the winter months, when rodents seek shelter in ... pediatrics at the University of Iowa Roy J. and ...
... was strongly believed since its launch that the doctor ... out any polyps, which is the main source// of ... in The New England Journal of Medicine says that ... out some polyps resulting in the development of life-threatening ...
... the Rajiv Gandhi Center’s Biotechnology and Regional Cancer Centre ... treating radiation related mucositis. // ,The mouthwash is ... effective in the treatment of mucositis, which is one ... radiation. Few of the symptoms are mouth sores and ...
... said Friday it would not withdraw a notification making ... and crossbones picture //as a warning but said its ... Sabha MPs from various parties protested the move saying ... workers. ,However, Health Minister Anbumani Ramadoss said ...
Cached Medicine News:Health News:Genes That Allow Brain Cancer-Causing Stem Cells to Resist Treatment Identified 2Health News:Genes That Allow Brain Cancer-Causing Stem Cells to Resist Treatment Identified 3Health News:Britain Plans Medical Hub to Meet India, China Challenge 2Health News:Pregnant Women Can Minimize Risk Of Rodent-Based Virus 2Health News:A Study Questions the Effectiveness of High Speed Colonoscopies 2
(Date:5/24/2013)... May 24, 2013  An international roster of experts ... 18, in Santa Monica, Calif. , ... therapies for MPM, a rare form of cancer that ... pleura, the lining of the chest. Hosted ... Institute, the 3rd Annual International Symposium on Lung-Sparing Therapies ...
(Date:5/24/2013)... , May 24, 2013  Heska Corporation (NASDAQ: HSKA, ... and specialty products, announced today that Dr. Robert ... and Jason Napolitano , executive vice president ... Marcum MicroCap Conference, which is being held May 30, 2013 ... Grand Hyatt Hotel. The Company,s presentation is ...
(Date:5/24/2013)... China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or ... in China , today announced that ... issued by Shanghai RAAS Blood Products Co., Ltd. ("Shanghai ... that on May 21, 2013, Ms. Siu ... shareholders of the Company, and her spouse, Mr. Tung ...
Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4
MBP's extra long 200 L pipet tip will reach the bottom of large tubes and vials, preventing your pipettor from contacting the sample container....
Designed to fit the Brinkmann Tranferpette and Treff Multi-Channel 300 L Pipettors, this tip provides extra space for repeat pipetting....
The LH ELISA kit is used for the quantitative measurement of LH in human serum or plasma....
... (LH) is a glycoprotein secreted by the ... and TSH, the intact LH molecule is ... These glycoproteins all have homologous alpha-subunits, however ... LH and FSH production and secretion are ...
Medicine Products: